From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.

WORST WEEK SINCE OCT.

U.S. markets had a downright awful week, with the Dow putting in its worst five-day stretch since October. The selloff started after the Federal Reserve moved up its forecast for interest rate hikes, saying it expects to do a pair in 2023 — an acknowledgment that the economy is recovering more quickly than the central bank predicted just a few months ago and that rising inflation threatens to slow that recovery down. Fed Chair Jerome Powell said the economy isn’t “out of the woods at this point” but that the labor market is looking strong. He also said inflation is rising faster than the Fed expected, and the Fed’s forecast now calls for 3.4 percent inflation in 2021, up from the prior estimate of 2.4 percent. That sent sectors like energy and industrials  that had been leading the recovery lower, with the broader market following suit. Then St. Louis Federal Reserve President James Bullard remarked that he expects the first rate hike to come as early as 2022. The S&P lost more than 1.5 percent on the week. 

VAX STOCKS SINK

The big COVID vaccine makers also had a miserable week, led by Novavax. The Maryland-based biotech fell 8 percent after reporting extremely positive results for its forthcoming vaccine, as investors looked to take profits on a stock that was at one point up close to 200 percent over the last year. BioNTech, Pfizer, and Moderna also fell on the Novavax news, given that they’re likely to face a new competitor in the market. Pfizer fell the least of the bunch; that stock has been remarkably steady despite being the first out of the gate with a life-saving vaccine that is helping to end a global pandemic. PFE shares are up just over 5 percent on the year while the S&P is up about 13 percent. 

SPACS TAKE NASDAQ

It was a fairly busy week for IPOs with two big names joining the Nasdaq. The cannabis review site Weedmaps and the at-home, genetic-testing powerhouse 23andMe both debuted on the exchange via SPACs. Weedmaps CEO Chris Beals said the company chose the SPAC route, merging with Silver Spike Acquisition Corp, in order to better “curate” its investor base. Weedmaps, which runs a SaaS platform for users to rate and buy from cannabis dispensaries in states where it’s legal — think Yelp for pot — received $579 million in a cash infusion in the deal. Meanwhile, 23andMe also went the SPAC route in its debut, merging with Richard Branson’s VG Acquisition Corp. in a deal that values the company at $3.5 billion. The stock spiked 21 percent on its first day of trade. 

HONEST EARNINGS 

Jessica Alba’s Honest Co. announced its first quarterly earnings release since going public, beating expectations on a narrower-than-expected loss and higher revenues, but showing signs of stagnation in some key areas. Honest’s diaper and wipes segment fell 2 percent year-over-year while digital sales rose just 2 percent, compared to 23 percent in the prior period. (The disappointing diaper sales were in line with Procter & Gamble’s numbers for its Pampers brand, for what it’s worth.) Honest has been branching out into new categories, which appears to be working. Sales of skin and personal care products and household and wellness products were up 42 and 53 percent year-over-year, respectively. The stock is trading roughly where it priced its IPO last month. 

BOTTLEGATE

The sponsors of the Euro 2020 soccer tournament are learning a valuable lesson about endorsements in the social media era. Shares of Coca-Cola slipped after Cristiano Ronaldo — one of the biggest soccer stars in the world with a social media following numbering half a billion — swapped two bottles of Coke for a bottle of water at his post-match press conference, urging people to drink “agua.” The clip immediately went viral online, wiping about $4 billion off Coke’s market cap and upsetting the delicate balance of power between superstars and brands in the online era. (Ronaldo started a bit of a trend at the Euro; Italian star Manuel Locatelli copied his move with the Coke bottles, and Manchester United’s Paul Pogba removed a strategically placed bottle of Heineken beer from his presser.) Coke, of course, is too big to feel much long-term pain from a fleeting viral video; the beverage giant said in April its global case volume is already back to pre-pandemic levels and the stock is up more than 15 percent in the last year.

Share:
More In Business
17 Digital Asset Firms Launch CMIC, Committing to Safer Markets and Working with Regulators
Soildus Labs, a market compliance and surveillance technology provider for crypto firms, has spearheaded the launch of the Crypto Market Integrity Coalition, a pledge committing to a safe and sensibly-regulated crypto industry. Kathy Kraninger, VP of Regulatory Affairs at Solidus Labs, discusses on Cheddar News' Closing Bell the biggest problems in the digital asset space that this new initiative plans to solve.
Stocks Close Mixed as Investors Process Earnings, Look Ahead to Thursday CPI
Stocks closed mixed Monday as a broader tech sell-off continued, leading the Nasdaq to close down 0.58%. Investors are keeping an eye on earnings, and also looking ahead to Thursday's CPI data, which will give an idea of how hot inflation could still be running. Steve Sosnick, Chief Strategist at Interactive Brokers, joins Closing Bell to discuss today's close, the Federal Reserve's plans to raise interest rates and taper asset purchasing, his 2022 market outlook, and more.
Chip Shortage Continues to Impact Automobile Production
The global chip shortage continues to weigh on the automotive industry. For example, Ford says it is suspending or cutting production at eight of its factories in North America through next week due to the shortage. Balu Balakrishnan, President and CEO of Power Integrations, joins Cheddar News' Closing Bell, where he elaborates on why the chip shortage has dragged into 2022.
Dan Ives: Apple is Likely 'Aggressively' Pursuing Peloton Takeover
Peloton has weathered a seemingly never-ending storm the past few months: PR blunders, sinking customer demand, and in recent weeks, reported cost-cutting and potential layoffs. Now, several companies are said to be in the mix as potential buyers: Amazon, Netflix, Disney, and Apple. How likely is it that one of these companies pursues a deal — and how likely is it that it will be Apple who buys Peloton? Dan Ives, Managing Director of Equity Research at Wedbush Securities, joins Closing Bell to discuss his thoughts about Apple pursuing a Peloton takeover,
Astra Scrubs NASA ELaNa 41 Space Launch, Sees Its Stock Fall
Astra aborted the launch for NASA ELaNa 41 Mission out of Cape Canaveral on Monday due to what was described as a minor issue, but the company's stock fell nearly 14 percent following the news. Jim Cantrell, CEO and co-founder of Phantom Space, which builds and launches spacecraft of its own, joined Cheddar to discuss the scrubbed mission. “The last thing you want is for this to go wrong, you're better to err on the side of safety expectations,” Cantrell explained, noting that the mission delay was a normal event.
TC BioPharm Goes Public, Looks to Future of Cancer, COVID-19 Cell Therapies
TC BioPharm, a biopharmaceutical company focused on developing cell therapy products targeting, went public on the Nasdaq in January. CEO Bryan Kobel joined Cheddar to talk about the company's IPO launch, its cancer-fighting therapeutics tech, and its potential for using its research to treat COVID-19. "The opportunity here for us is to really get safety data and covid and expand into other areas," Kobel said. "So from COVID, where we hope to treat patients, hopefully maybe the elderly population, populations that that really can't handle the antivirals because they're too hard in the system, well then we'll expand out into maybe severe influenza Ebola, other viral and viral infections where we think we can be helpful."
Load More